Metabolic plasticity of T cell fate decision

Chin Med J (Engl). 2024 Apr 5;137(7):762-775. doi: 10.1097/CM9.0000000000002989. Epub 2024 Mar 26.

Abstract

The efficacy of adaptive immune responses in cancer treatment relies heavily on the state of the T cells. Upon antigen exposure, T cells undergo metabolic reprogramming, leading to the development of functional effectors or memory populations. However, within the tumor microenvironment (TME), metabolic stress impairs CD8 + T cell anti-tumor immunity, resulting in exhausted differentiation. Recent studies suggested that targeting T cell metabolism could offer promising therapeutic opportunities to enhance T cell immunotherapy. In this review, we provide a comprehensive summary of the intrinsic and extrinsic factors necessary for metabolic reprogramming during the development of effector and memory T cells in response to acute and chronic inflammatory conditions. Furthermore, we delved into the different metabolic switches that occur during T cell exhaustion, exploring how prolonged metabolic stress within the TME triggers alterations in cellular metabolism and the epigenetic landscape that contribute to T cell exhaustion, ultimately leading to a persistently exhausted state. Understanding the intricate relationship between T cell metabolism and cancer immunotherapy can lead to the development of novel approaches to improve the efficacy of T cell-based treatments against cancer.

Publication types

  • Review

MeSH terms

  • CD8-Positive T-Lymphocytes* / metabolism
  • Cell Differentiation
  • Humans
  • Immunotherapy / methods
  • Neoplasms* / metabolism
  • Neoplasms* / therapy
  • Tumor Microenvironment